欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/0287/001
药品名称Imipenem + Cilastatina Hospira
活性成分
    • Cilastatin sodium salt 530.0 mg
    • Imipenem monohydrate 530.0 mg
剂型Powder for solution for infusion
上市许可持有人Hospira UK Limited Queensway Royal Leamington Spa Warwickshire CV31 3RW UK
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Italy (IT)
    • Cyprus (CY)
      IMIPENEM/CILASTIN PWD FOR SOLUTION FOR INFUSION
许可日期2010/06/10
最近更新日期2024/12/12
药物ATC编码
    • J01DH51 imipenem and cilastatin
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase